---
category: news
title: "Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma"
excerpt: "Hepatocellular carcinoma (HCC) is the most common form of primary adult liver cancer. After nearly a decade with sorafenib as the only approved treatment, multiple new agents have demonstrated efficacy in clinical trials, including the targeted therapies regorafenib, lenvatinib and cabozantinib, the anti-angiogenic antibody ramucirumab, and ..."
publishedDateTime: 2020-01-03T14:23:00Z
sourceUrl: https://www.nature.com/articles/s41575-019-0240-9
type: article
quality: 32
heat: 32
published: false

provider:
  name: Nature
  domain: nature.com

topics:
  - AI

images:
  - url: https://www.bing.com/th?id=ON.3E2F405DF8B5E5D76FACA51BA69229EB
    width: 685
    height: 596
    title: "Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma"

secured: "FAKCd2cHcAqcI0A02kQuX75+TSiQ2nA/GV+otwc894ieju3HqE8qlrS49wPxdhv9ZOVeqxTNUuglgcZApzI16JuTxE0Gn2gI2AGVQHwG6a3uJ+gONIPMrfeVb2SAs5ySHxhevl8QrAq6yqpQ6Xec+dOhnRAwvux1hBHsX5SACMFMzVQBCVlI2Fn2Jtn+bcrXHQSzOLno2FKQD8/u2erc0E+1xXQINhna6t3LAfegSzkFCpNBFQeYwVT6wrN2JaMFTot5J4uIBspmYJXVCqoqdg==;DpzK+N6DWBAJI8g66Q6UwA=="
---

